Simon Piggott

Honoured to have received the Sinead Kinsella bursary at @IrishNephSoc. Endlessly impressed/motivated by @MaireadH92’s update at this year’s meeting

@RowanZyada great tweetorial. Gila 💪🏻 @NSMCInternship @NephMadness

Back by popular demand, the INS is taking part in #Nephmadness 2024. 🏀 Open to any nephrology department or group with an Irish connection. 👇 See below for details. 👉 Complete your bracket at tourneytopia.com/ajkd/nephmadne… 👉 Fill out the Google form: forms.gle/nsKTapPwNsQaKM…

🎊 We are excited to introduce the 10th NSMC internship class of 2024🎊. Learn their names and follow them because they will be producing the visual abstracts, journal clubs, blog posts, tweetorials, and podcasts! These are also the future leaders of nephrology.

Non-steroidal MRAs reintroduce these medications to the conversation in the wake of SGLT2i, but have we had the better option since 1999?

#NephMadness - MRA bracket. Has finerenone done what spironolactone/eplerenone couldn’t? If the Fidelio trial was recreated with spiro, would the outcomes be similar/even better?

@Stones__ @Stones__ a strong bracket (biased perhaps). 2 generations of medications in the same class - study/trial design development in the 15 - 20 years between them creates a lot of discussion

MRAs from @PiggottSimon #NephMadness

🇮🇪 Tertiary nephrology centre @PiggottSimon Jan 2020-Mar 2022 What was permcath experience? Higher use in older population. Most frequent reason for exchange was line sepsis followed by poor flows. Most frequent reason for removal was renal recovery, then AVF. #KidneyWk

Very exciting to have our research featured in the media today! Looking forward to another great day of #SfEBES2021

“Hello this is Simon. The…. ?Med reg on call?” #changeover